Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)

Abstract Peripheral T-cell lymphomas (PTCLs) are a group of highly aggressive malignancies with generally poor prognoses, and the first-line chemotherapy of PTCL has limited efficacy. Currently, several novel targeted agents, including histone deacetylase inhibitors (HDACis), have been investigated...

Descripció completa

Dades bibliogràfiques

Autors principals:	Guang Lu, Shikai Jin, Suwen Lin, Yuping Gong, Liwen Zhang, Jingwen Yang, Weiwei Mou, Jun Du
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-08-01
Col·lecció:	Clinical Epigenetics
Matèries:	Histone deacetylase HDACi PTCL Romidepsin Belinostat Chidamide
Accés en línia:	https://doi.org/10.1186/s13148-023-01531-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!